Drug Discovery & Pharmaceuticals

RSS

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, has published new findings on the generation and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

From Bio-Rad Laboratories 11 Jan 2019

Quanterix extends oncology footprint with accelerated launch of next gen SP-X platform and CorPlex validated 10-Plex

Quanterix announce launch of its Simoa SP-X Imaging and Detection System, 10-Plex Simoa CorPlex Cytokine Panel, and broad menu of additional multiplex panels.

From Quanterix 10 Jan 2019

Aptamer Group and AstraZeneca to develop new drug delivery vehicles

Aptamer Group today announced it has signed an agreement with AstraZeneca to explore the potential of using aptamer technology to target the kidney.

From AstraZeneca 10 Jan 2019

Drug development options diversified with new manganese catalyst

A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

9 Jan 2019

Protein discovery could lead to mosquito "birth control"

Researchers have discovered a way of preventing mosquito eggs from hatching, paving the way for drugs that could serve as “birth control” within mosquito populations.

9 Jan 2019

TARA Biosystems and Insilico Medicine collaborate to discover novel therapies for cardiac disease

TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and risk assessment applications and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases, announced today the launch of a collaboration to discover and develop novel therapies for cardiac disease and diseases associated with cardiac muscle aging.

9 Jan 2019

Scientists develop new resource-saving green alternative for drug production

For the production of drugs, pesticides and smartphone displays, most of the processes are cost-intensive and generate a large amount of waste. Scientists at the University of Göttingen have now succeeded in developing a resource-saving "green" alternative. The results were published in Nature Catalysis.

8 Jan 2019

CytoReason enters into drug discovery collaboration agreement with Pfizer

CytoReason, a leader in machine learning for drug discovery and development, announced today that it has entered into a collaboration agreement with Pfizer Inc. that will leverage CytoReason's cell-centered models of the immune system.

8 Jan 2019

Inhalable mRNA offers hope for patients with lung disease

Scientists have reported the success of an inhalable mRNA therapy that can induce the production of a target protein in the lungs of mice.

4 Jan 2019

Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics 2019

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at The Longevity Therapeutics 2019 in San Francisco, 30 of January.

30 Dec 2018

Novel ferrocenyl phosphines developed as potent antimalarial drugs

A team of researchers from the Singapore University of Technology and Design and Nanyang Technological University have developed novel ferrocene-based molecules that impair the malaria parasite's metabolic function leading to parasite death.

20 Dec 2018

Researchers synthesize new compound that inhibits replication of hepatitis C virus

A new compound that inhibits the replication of hepatitis C virus in several stages of its lifecycle - and is also capable of acting on bacteria, fungi and cancer cells - has been synthesized by researchers at São Paulo State University in Brazil.

19 Dec 2018

Study uncovers initial folding mechanism of membrane proteins, key in design of new drugs

An international team coordinated by the Interdisciplinary Research Structure in Biotechnology and Biomedicine of the University of Valencia has proved how the folding of membrane proteins begins before they are inserted into biological membranes, a fact that has been central to the biochemical research for decades.

19 Dec 2018

Drug Discovery & Pharmaceuticals

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

Quanterix extends oncology footprint with accelerated launch of next gen SP-X platform and CorPlex validated 10-Plex

Aptamer Group and AstraZeneca to develop new drug delivery vehicles

Drug development options diversified with new manganese catalyst

Protein discovery could lead to mosquito "birth control"

TARA Biosystems and Insilico Medicine collaborate to discover novel therapies for cardiac disease

Scientists develop new resource-saving green alternative for drug production

CytoReason enters into drug discovery collaboration agreement with Pfizer

Inhalable mRNA offers hope for patients with lung disease

Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics 2019

Novel ferrocenyl phosphines developed as potent antimalarial drugs

Researchers synthesize new compound that inhibits replication of hepatitis C virus

Study uncovers initial folding mechanism of membrane proteins, key in design of new drugs

DNA “webs” shown to promote metastasis in ovarian cancer

Horizon Discovery partners with C4XD to validate novel synthetic lethal oncology targets

Developing the Next Generation of Water-soluble DREADDs

Researchers discover how MAPK translocation leads to drug resistance in melanoma

National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development

Getting the Most Out of the CLARITY Technique

Answering the Biggest Neurological Research Questions of Today

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News